Nova Scotia Health

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL	acquired partial lipodystrophy, partial lipodystrophy	Active, not recruiting	Phase 3	2026-06-15	NCT05164341
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy	Arrhythmias, Cardiac, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death, Death, Sudden, Death, Sudden, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arrhythmogenic right ventricular cardiomyopathy, cardiac arrest, cardiomyopathy, cardiovascular disorder, congenital heart disease, heart disorder	Recruiting	Phase 2	2026-03-12	NCT06174220
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 3	2025-03-20	NCT05169112
Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation Glaucoma	exfoliation glaucoma, exfoliation syndrome, eye disorder, iris disorder, uveal disorder	Recruiting	Not applicable	2024-08-21	NCT04416724

Clinical trials